Stock Scorecard



Stock Summary for Johnson & Johnson (JNJ)

Total Score

14 out of 29

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for JNJ

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for JNJ

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for JNJ

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for JNJ

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Financial Details for JNJ

Company Overview

Company Name Johnson & Johnson
Country USA
Description Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 9/30/2022
Next Earnings Date 1/24/2023

Stock Price History

Last Day Price 177.24
Last Day Volume 3,058,608
Average Daily Volume 6,585,391
52-Week High 183.08
52-Week Low 151.86
Last Price to 52 Week Low 16.71 %

Valuation Measures

Trailing PE 24.69
Industry PE 36.99
Sector PE 93.21
5-Year Average PE 17.23
Free Cash Flow Ratio 13.58
Industry Free Cash Flow Ratio 8.14
Sector Free Cash Flow Ratio 37.54
Book Value Per Share Most Recent Quarter 28.51
Price to Book Ratio 6.21
Industry Price to Book Ratio 6.06
Sector Price to Book Ratio 15.42
Price to Sales Ratio Twelve Trailing Months 4.83
Industry Price to Sales Ratio Twelve Trailing Months 66.70
Sector Price to Sales Ratio Twelve Trailing Months 25.17

Share Statistics

Total Shares Outstanding 2,614,480,000
Market Capitalization 463,390,435,200
Institutional Ownership 0.00 %

Dividends

Ex-Dividend Date 11/21/2022
Last Dividend Amount 1.13
Current Dividend Amount 1.13
Dividend Aristocrat?
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00 %
Trailing Annual Dividend Rate 5.51
Trailing Annual Dividend Yield 2.55 %
5-Year Average Dividend Yield 0.00 %
5-Year Dividend Payments Count 21
Dividend Payout Ratio 0.00 %

Income Statement

Quarterly Earnings Growth YOY 22.60 %
Annual Earnings Growth 41.89 %
Reported EPS Past Year 7.81
Reported EPS Prior Year 9.80
Net Income Twelve Trailing Months 19,157,000,000
Net Income Past Year 20,878,000,000
Net Income Prior Year 14,714,000,000
Quarterly Revenue Growth YOY 1.90 %
5-Year Revenue Growth 5.64 %

Balance Sheet

Total Cash Per Share 13.05
Total Cash Most Recent Quarter 34,128,000,000
Total Cash Past Year 33,492,000,000
Total Cash Prior Year 26,666,000,000
Net Cash Position Most Recent Quarter 6,525,000,000
Net Cash Position Past Year 1,376,000,000
Long Term Debt Past Year 32,116,000,000
Long Term Debt Prior Year 34,434,000,000
Total Debt Most Recent Quarter 27,603,000,000
Equity to Debt Ratio Past Year 0.70
Equity to Debt Ratio Most Recent Quarter 0.73
Current Ratio Most Recent Quarter 1.43
Total Stockholder Equity Past Year 74,023,000,000
Total Stockholder Equity Prior Year 63,278,000,000
Total Stockholder Equity Most Recent Quarter 74,599,000,000

Options

Put/Call Ratio 1.05
Has Options Options Chain
Liquidity Rating

Technical Analysis

MACD 2.44
MACD Signal 2.12
20-Day Bollinger Lower Band 161.35
20-Day Bollinger Middle Band 166.22
20-Day Bollinger Upper Band 171.09
Beta 0.57
RSI 65.61
50-Day SMA 169.32
200-Day SMA 147.22

System

Modified 11/26/2022 4:08:35 PM